The Use of Omalizumab in Food Oral Immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s00005-016-0420-z.pdf
Reference73 articles.
1. Achatz G, Lamers M, Crameri R (2008) Membrane bound IgE—the key receptor to restrict high IgE levels. Open Immunol J 1:25–32
2. Anagnostou K, Clark A, King Y et al (2011) Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 41:1273–1281
3. Andrews AL, Holloway JW, Holgate ST et al (2006) IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol 176:7456–7461
4. Beck LA, Thaci D, Hamilton JD et al (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371:130–139
5. Begin P, Dominguez T, Wilson SP et al (2014a) Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using omalizumab. Allergy Asthma Clin Immunol 10:7
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omalizumab as the first drug of genetically engineered biological therapy: New expectations and relevance of use in bronchial asthma;Meditsinskiy sovet = Medical Council;2024-09-02
2. Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?;Allergy;2024-04-19
3. Efficacy of biological agents combined with oral immunotherapy (OIT) for food allergy: a protocol for a systematic review and meta-analysis;BMJ Open;2024-02
4. Best practices for administering food immunotherapy in the clinic;Encyclopedia of Food Allergy;2024
5. Theoretical and practical aspects of food allergy in the XXI century. EAACI 2021;Experimental and Clinical Gastroenterology;2022-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3